Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System
|
|
- Morgan Morton
- 5 years ago
- Views:
Transcription
1 Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System Kelly Goodson, PharmD; Erin Roach, Pharmd; Susan Bear, PharmD; Lisa Davidson, MD Carolinas HealthCare System is one of the nation s largest healthcare systems serving patients throughout North and South Carolina. In 2012, Carolinas HeathCare System endorsed a system approach to antimicrobial stewardship to improve the use of antimicrobial agents across eight acute care facilities and four rehab facilities within the system, commonly referred to as primary enterprise facilities. This program, The Antimicrobial Support Network (ASN), was implemented under the direction of Kelly Goodson, PharmD, ASN pharmacy manager; Susan Bear, PharmD, CHS Associate Vice President of Clinical Pharmacy Services; and Lisa Davidson, MD, ASN Medical Director. The ASN utilized key concepts from the Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship as well as outcomes from an active antimicrobial stewardship program already initiated within the system. 1 Carolinas Healthcare System NorthEast (CHS- NorthEast), a regional 457- bed medical center implemented an antimicrobial stewardship program in 2010 due to increasing rates of antimicrobial resistance, increasing rates of clostridium difficile infection, and increasing antimicrobial expenditures. The program realized significant reductions in antimicrobial utilization leading to a 30% reduction in antimicrobial drug spend per adjusted patient day, an estimated cost avoidance of greater than $1,500,000, and a return on investment of 388% (see Figure 1). Figure 1. Antimicrobial Drug Spend per Adjusted Patient Days Table 1. Supplements to the core active antimicrobial stewardship strategies Aminoglycoside and vancomycin pharmacokinetic monitoring Renal dose adjustment protocols Prolonged infusion protocols (piperacillin/tazobactam and meropenem) Intravenous to oral conversion Empiric treatment guidelines Duration of therapy guidelines Formulary review of antimicrobial agents In 2013, prior to the launch of the ASN, a gap analysis performed illustrated that primary enterprise facilities had numerous elements considered as supplements to the core antimicrobial stewardship strategies (see Table 1). 1 Elements lacking included a system for targeted review of antimicrobial therapy, criteria for antimicrobial de- escalation, metrics for antimicrobial utilization and program monitoring, and information technology support and systems for enhancing antimicrobial review and data collection. Based on the success of the antimicrobial stewardship program at CHS- NorthEast and literature review, it was determined the core strategy of the ASN would be prospective audit with intervention and feedback in patients receiving target antimicrobials (see Table 2), patients receiving 3 or more antimicrobial
2 agents, and patients receiving any antimicrobial agent for 72 hours. A report utilizing the electronic medical record for the system was created to identify patients with the above criteria. The electronic medical record was also utilized to document interventions at the facility level and generate daily notes for the medical record. Table 2. Target antimicrobials Aztreonam Meropenem Doripenem Cefepime Ceftaroline Ertapenem Tigecycline Daptomycin Linezolid Amphotericin Caspofungin Voriconazole Posaconazole The ASN began the task of implementing stewardship programs across the remaining acute care facilities with a rolling implementation schedule from August, 2013 through January, In order to translate the success of the antimicrobial stewardship program at CHS- NorthEast on both a local and system- wide scale, the initial model for the ASN was designed as a hub and spoke model (see Figure 2). The ASN central office is staffed by a Medical Director and Clinical Pharmacy Manager who designed the roll- out, policy, education, training, and evaluation of metrics. The central office also serves as a system resource for coordinating all stewardship- related policies and clinical guidelines. University Figure ASN Mode ASN CENTRAL OFFICE The primary objective of the ASN during the first year was to Pineville Union establish a stewardship network for six facilities performing daily stewardship review and feedback to clinicians. This Mercy would be achieved by a multi- disciplinary team of pharmacists and physicians making recommendations to healthcare providers encouraging safe, appropriate use of antimicrobials and reduce overall antimicrobial resistance and expenditures. The following ASN goals were developed for both the system level and individual facilities: Goal 1: Decrease antimicrobial utilization (DOT) by 5% (stretch goal 10%) Goal 2: Decrease antimicrobial costs by 5% compared to Year 2013 Goal 3: Increase Intervention Acceptance Rate to 85% (stretch goal 90%) Goal 4: Adequately staff the program at each facility by greater than 90% The aforementioned goals are utilized to track the effectiveness of the program at both the system and facility level. The ASN central office generates the data on a quarterly basis which includes antimicrobial utilization (days of therapy (DOT) per 1000 patient days, antimicrobial purchases (expenditures per 1000 adjusted patient days), intervention acceptance rates, and self- reported facility staffing rates. The metrics chosen are in line with CDC- proposed national standards for monitoring antibiotic utilization. To adequately summarize, review, and illustrate success of the program, the ASN developed a score card to track metrics at both the system and facility level (see Figure 3). CMC NorthEast
3 Figure 3. Antimicrobial Support Network Scorecard Antimicrobial days- of- therapy, purchasing data, intervention data, and ASN staffing has been tracked since the beginning of the program. Upon completion through Q1 2014, the ASN central office reviewed the initial eight- month progress. Although significant declines in antimicrobial utilization and expenditures were seen, there was significant variability between facilities regarding staffing coverage. Facilities with dedicated, full- time ASN pharmacists were able to review more patients and perform more interventions. Facilities with pharmacists only partially dedicated to the ASN role were frequently reassigned to other areas of focus or were not as efficient in their daily review. With staffing levels averaging 71%, the actual number of patients reviewed and interventions made was only 52%. This translated to an additional 15-20% decrease in drug spending and an 8-11% decrease in DOTs not realized. Plans to bring on new facilities without pharmacists fully dedicated to the ASN role would widen this gap. Goals for 2015 included expanding the scope the ASN program to include patients with positive blood cultures, positive cultures for multi- drug resistant organisms, bug- drug mismatch, and early identification of patients with antibiotic- related nephrotoxicity. In order to improve ASN coverage at all facilities, increase efficiency in daily review, and expand the scope of practice, the ASN needed dedicated pharmacists 7 days a week. As the ASN continued to develop business plans and staffing models to justify expansion of the program, the Centers for Disease Control and Prevention (CDC) published national guidelines on the core elements of antimicrobial stewardship programs. 2 A second gap analysis for each primary enterprise facility, further justifying the need for program expansion. In recognition of the urgency of this growing national healthcare crisis, President Obama issued an Executive Order in September 2014 to develop a national plan to combat antimicrobial resistance. 3 A key component of this plan is to develop national antibiotic standards and require all acute- care facilities to have active antimicrobial stewardship programs. Based on the initial success of the ASN and the timely publishing of the Core Elements of a Hospital Antimicrobial Stewardship Program as well as the Whitehouse Executive Order Combating Antibiotic- Resistant Bacteria, Carolinas HealthCare Senior Leadership approved the expansion of the ASN. As of March 2015, the federal government is now proposing antimicrobial stewardship as a CMS Condition of Payment for
4 Figure ASN Model In January, 2015, the conversion to the new staffing model (see Figure 4), as well as recruitment for new infectious diseases/antimicrobial stewardship pharmacists began. Three ASN divisions were established: North, Central and South. Each of the teams is led by an ASN Clinical Team Leader with PGY 2 or equivalent training in Infectious Diseases and stewardship, together with one to two additional clinical staff pharmacists and an additional infectious diseases pharmacist. Pharmacists in these teams dedicate 100% of their time to stewardship activities including daily review of patients, clinician education, and development and implementation of system- wide initiatives. While these pharmacists are in a centralized location, they are dedicated to one to two facilities, thereby serving as the stewardship expert available to all clinicians in their respective facilities. Prior to conversion to the new ASN
5 staffing model, the ASN decreased antimicrobial utilization (days of therapy per 1000 patient days) by 8.4%. The ASN scorecard also illustrates the impact the initial ASN staffing model had on antimicrobial expenditures and intervention acceptance rates (see Figure 6). The new staffing model for the ASN has been very successful thus far. At the completion of quarter 2, all pharmacist positions were filled with ASN pharmacist orientation and training expected by the beginning of quarter 4, The new staffing model has led to significant growth for the system- wide ASN program as well as growth at the facility level. Hospital D experienced a modest decrease in antimicrobial utilization, a 3.8% decrease comparing 2014 utilization to 2013 (see Figure 7). Due to pharmacist staffing constraints throughout 2014, the program was staffed 40% of ASN eligible days with 635 interventions documented for the calendar year. After implementation of the new staffing model, ASN was staffed 100% of ASN eligible days with an 11.5% reduction in antimicrobial utilization (see figure 7) and a 2- fold increase in interventions documented comparing year- to- date 2015 to Figure 7. Hospital D Antimicrobial Utilization Hospital D Top Antimicrobial Agents Figure 5. Antimicrobial Utilization: 2014 vs DOT / 1000 palent days CHS Anlmicrobial Agents vs % Figure ASN Scorecard
6 Hospital G did not have the band- width within the current pharmacy staffing structure to implement ASN services prior in With the new ASN staffing model, the ASN was implemented at hospital D in January, This facility experienced a 17.8% reduction in antimicrobial utilization (see Figure 8) and a 28.9% reduction in antimicrobial expenditures comparing year- to- date 2015 to Figure 8. Hospital G Antimicrobial Utilization Hospital G Top Antimicrobial Agents vs % System- wide, the new staffing model has significantly impacted ASN goals and metrics. A reduction in antimicrobial utilization of 7.5% has been realized comparing year- to- date 2015 to 2014 as well as a 6.7% reduction in antimicrobial expenditures (see Figures 9 and 10). There has also been a 2- fold increase in interventions documented comparing year- to- date 2015 to 2014, with an 88% acceptance rate. In addition, the ASN has been launched at four rehab facilities in quarter 3, will be launched at three additional acute care facilities in quarter 4, and will expand coverage to weekends and holidays beginning in quarter 4. The goal by 2016 is to include all acute care and rehab facilities within the primary enterprise. In 2016, the ASN will expand to include Levine Children s Hospital. The centralization plan and use of virtual stewardship review will ensure adequate coverage of patients requiring Antimicrobial Support Network services. Figure 9. Antimicrobial Utilization: 2015 (YTD) vs CHS Top Antimicrobial Agents
7 1. Dellit TH, Owens RC, McGowan JE Jr, et al; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44: CDC. Core elements of hospital antibiotic stewardship programs. Atlanta, GA: US Department of Health and Human Services, CDC; Available at elements.html press- office/2014/09/18/executive- order- combating- antibiotic- resistant- bacteria. Accessed April 15, Figure ASN Scorecard (YTD) resistant_bacteria.pdf. Accessed April 15, 2015
Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016
Adult Inpatient Antibiogram Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates January to December 2016 Department of Pathology Camille Hamula, PhD Director, Clinical Microbiology
More informationMONTEFIORE MEDICAL CENTER
DEPARTMENT OF PHARMACY MONTEFIORE MEDICAL CENTER SUBJECT: MANUAL CODE: Restricted Drugs Policy, Antibiotic Restriction PH-R-5 DATE ISSUED: August, 1976 DATE REVISED: September 2000, October 2003, September
More informationTestimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and
Testimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and The Society for Healthcare Epidemiology of America (SHEA) to the U.S. House of Representatives Appropriations
More informationEffect of piperacillin/tazobactam restriction on usage and rates of acute renal failure
Journal of Medical Microbiology (2016), 65, 195 199 DOI 10.1099/jmm.0.000211 Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure Michael A. Lorenz, 1,2 Ryan P. Moenster
More informationKeely Ray, PharmD, CGP, CIC, FASCP Consultant Pharmacist Neil Medical Group Chair, NCAP Chronic Care Practice Forum. NCAP Executive Director
2016 NCAP Chronic Care Practice Forum Meeting Sheraton Greensboro at Four Seasons Greensboro, North Carolina March 16-18, 2016 Developed with UNC Eshelman School of Pharmacy Co-Sponsored by Campbell University
More informationOutline of presentation. Pinyo Rattanaumpawan; Sajja Supornpun; Basic Concepts of ASP Research to Practice in ASP ASP Siriraj
1 Pinyo Rattanaumpawan; MD, MSCE, PhD Division of Infectious Diseases and Tropical Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University Sajja Supornpun; BPharm, MS Department of Pharmacy,
More informationJourney to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer
Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical
More informationOn behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide
Transmitted by Jonathan Nurse, Director of Government Relations, IDSA The Infectious Diseases Society of America s (IDSA) Fiscal Year 2015 Funding Statement Submitted to the House Appropriations Subcommittee
More informationDecember 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide
Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,
More informationConference For Healthcare Transparency & Patient Safety. Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015
Conference For Healthcare Transparency & Patient Safety Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015 2 Objectives After this presentation, participants will be able to: Explain the importance
More informationWorkHealthy Hospitals: A National Perspective. Heather Berdanier, Strategic Alliances Manager
WorkHealthy Hospitals: A National Perspective Heather Berdanier, Strategic Alliances Manager Presentation Goals About WorkHealthy Hospitals & WorkHealthy America SM Early Results from WorkHealthy America
More informationFollow this and additional works at:
Regis University epublications at Regis University Celebration of Scholarship and Research Center for Scholarship and Research Engagement Spring -11-17 Implementation of education with ongoing feedback
More informationThink Globally: Strategies to Improve the Culture of Antibiotic Prescribing
Think Globally: Strategies to Improve the Culture of Antibiotic Prescribing October 11, 2017 Paul Lewis, PharmD, BCPS (AQ-ID) Johnson City Medical Center Johnson City, TN 1 Outline Introduction to stewardship
More informationReducing Opioid Over- Prescribing in a Large Integrated Health Care System
Session L6 This presenter has nothing to disclose It Takes a Village to Curb the Prescription Opioid Epidemic: Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Joel D. Hyatt,
More informationThe STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018
The STOP Measure Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 AHIP s Safe, Transparent Opioid Prescribing (STOP) Initiative Methodology
More informationPharmacist Opportunities within Telemedicine
Pharmacist Opportunities within Telemedicine Bryan Robinette, PharmD, BCPS-AQ Cardiology, Sonia Everhart, PharmD, BCPS, BCCCP Desiree Kosmisky, PharmD, BCCCP March 13 th, 2017 Disclosures Sonia Everhart,
More information2/9/2016. A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events. Objectives:
A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events Michigan Pharmacist Association February 28, 2016 Steven Johnson, Pharm.D. Regional Clinical Director Gay Alcenius,
More informationD DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2
Journal of Pharmacy and Pharmacology 5 (2017) 607-615 doi: 10.17265/2328-2150/2017.09.001 D DAVID PUBLISHING Comparative Evaluation of Pharmacist-Managed Vancomycin Dosing in a Community Hospital Following
More informationPREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE
PREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE DISCLOSURE STATEMENT Brooke Hudspeth is employed by The Kroger Co. No other conflicts
More informationJanuary 17, Re: Secretary s Advisory Committee on National Health Promotion and Disease Prevention Objectives for Healthy People 2030
January 17, 2019 Don Wright, MD, MPH, FAAFP Deputy Assistant Secretary for Health Office of Disease Prevention and Health Promotion Department of Health and Human Services Tower Building 1101 Wootton Parkway,
More informationTITLE NALOXONE STATEWIDE STANDING ORDER UPDATE & NARCAN ACCESS ONE-DAY EVENT
TITLE NALOXONE STATEWIDE STANDING ORDER UPDATE & NARCAN ACCESS ONE-DAY EVENT WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association PRESENTER Kevin Gabbert, LISW, IAADC
More informationClinical Safety & Effectiveness Cohort 18 Team #8 South Texas Veterans Health Care System Medical Intensive Care Unit Vancomycin De-escalation Project
Clinical Safety & Effectiveness Cohort 18 Team #8 South Texas Veterans Health Care System Medical Intensive Care Unit Vancomycin De-escalation Project DATE 1 The Team Team champion: Marcos I. Restrepo,
More informationEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Health in Europe: A Strategic Approach
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Health in Europe: A Strategic Approach Comments by the ESCMID Executive Committee, http://www.escmid.org The European Society
More informationAnnual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016
Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016 Sarah Gierhart and Uzo Chukwuma Approved for public release. Distribution is unlimited. The views
More informationMarch 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments
March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE
More informationIMPLEMENTING ANTIMICROBIAL STEWARDSHIP IN A CRITICAL ACCESS HOSPITAL
IMPLEMENTING ANTIMICROBIAL STEWARDSHIP IN A CRITICAL ACCESS HOSPITAL The nitty gritty of a practical approach. Cameale Johnson, PharmD MBA South Peninsula Hospital Homer, Alaska What this presentation
More informationClinical Research Resources
Clinical Research Resources SOM New Faculty Orientation August 2017 Pamela G. Terry, MBA, JM Associate Executive Director, University Resources ACTSI Atlanta Clinical & Translational Science Institute
More informationOn behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in
Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education
More informationIMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE:
IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE: IMPACT OF A PHARMACY DEPARTMENT-WIDE APPROACH IN A COMMUNITY HOSPITAL SETTING November 2014 Monica Dorobisz,
More informationExpanding Access to Mental Health Services for Low-Income Patients. Introductory Webinar
Expanding Access to Mental Health Services for Low-Income Patients Introductory Webinar Webinar Technology Opening Your Line 1. Make sure Telephone is the option selected 2. Dial your Access Code 3. Enter
More informationAntibiotic Dosing in the Elderly
Antibiotic Dosing in the Elderly Philip Chung, PharmD, MS, BCPS Nebraska ASAP Community Network Pharmacy Coordinator Nebraska Medicine Disclosure I have no relevant disclosure The presentation includes
More informationOther β-lactam. A. Carbapenems:
A. Carbapenems: Other β-lactam Carbapenems are synthetic β-lactam antibiotics Differ in structure from the penicillins in that the sulfur atom of the thiazolidine ring. Imipenem, meropenem, doripenem,
More informationOregon Opioid Overdose Prevention Initiative
Oregon Opioid Overdose Prevention Initiative Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Association of Hospitals & Health Systems February 2017
More information3 rd Immunization Congress: Financing Across the Lifespan Report Out
3 rd Immunization Congress: Financing Across the Lifespan Report Out AAP American Academy of Pediatrics GSA Gerontological Society of America NFID National Foundation for Infectious Disease NVPO National
More informationSustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care. Presenter: Malinda Boehler, MSW, LCSW 15 March 2017
Sustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care Presenter: Malinda Boehler, MSW, LCSW 15 March 2017 Routine HIV Screening in Community Health Centers: Making the
More informationOral Presentation to the H.E.L.P. Committee on February 14, 2012 Philip A. Pizzo, MD
Oral Presentation to the H.E.L.P. Committee on February 14, 2012 Philip A. Pizzo, MD 1. I am Dr. Philip A Pizzo, Dean of the Stanford University School of Medicine as well as Professor of Pediatrics and
More informationOpioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative
Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative Objectives Summarize the current crisis at the national and Iowa state level.
More informationAyrshire and Arran NHS Board
Paper 3 Ayrshire and Arran NHS Board Monday 19 Healthcare Associated Infection Position Report Author: Bob Wilson, Infection Control Manager Babs Gemmell, Business Manager Sponsoring Director: Fiona McQueen,
More informationMinistry of Children and Youth Services. Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW
Chapter 4 Section 4.01 Ministry of Children and Youth Services Autism Services and Supports for Children Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of
More informationMODULE 1: Healthcare System in Kenya. Unit 1.2: Performance of the Kenya healthcare system
MODULE 1: Healthcare System in Kenya Unit 1.2: Performance of the Kenya healthcare system Contents Performance of the healthcare system Access, coverage, quality, safety, equity Effectiveness, Efficiency
More informationKAISER PERMANENTE OF GEORGIA COMMUNITY BENEFIT REPORT
2016 KAISER PERMANENTE OF GEORGIA COMMUNITY BENEFIT REPORT Partnering to Build Healthy Communities At Kaiser Permanente Georgia, our commitment to improving health has been going strong for more than 30
More informationCommunity-Based Point-of-Care Testing: From Innovative Care Model to Common Practice
Community-Based Point-of-Care Testing: From Innovative Care Model to Common Practice Donald G. Klepser, PhD, MBA Associate Professor University of Nebraska Medical Center Brian Bobby Rite Aid Vice President,
More informationOutline. Pharmacists Improving Outcomes in the Management of. of Infectious Diseases. Threats Against Desired Outcomes 7/11/2010
Pharmacists Improving Outcomes in the Management of Infectious Diseases Christine Teng, MSc(Clin Pharm) BCPS Assistant Professor Dept of Pharmacy, National University of Singapore Principal Pharmacist
More informationBoth adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members)
Infectious Diseases Society of America Emerging Infections Network Report for Query: Antimicrobial Drug Shortages 2016 Overall response rate: 701/1,597 (44%) physicians responded from 3/22/16 to 4/13/16.
More informationTragedy to Transformation Patient and Family Advocacy and Carolinas HealthCare System HEN. Julia Lanham Michael Ruhlen
Tragedy to Transformation Patient and Family Advocacy and Carolinas HealthCare System HEN Julia Lanham Michael Ruhlen Linking Patient and Family Engagement (PFE) to Outcomes Completed Deep Dive with each
More informationAccelero Identifies Opportunities to Provide Greater Value in Hip Fracture Care
Accelero Health Partners, 2015 WHITE PAPER Accelero Identifies Opportunities to Provide Greater Value in Hip Fracture Care Jason Pry, Senior Director ABSTRACT Every year more than a quarter of a million
More informationFaculty Advisors: Catherine O Brien, PharmD and Holly Maples, PharmD Location: Arkansas Children s Hospital
Faculty Advisors: Catherine O Brien, PharmD and Holly Maples, PharmD Location: Arkansas Children s Hospital 2010 Pharmacy Practice Student Research Fellowship Title: Evaluation of Vancomycin Pharmacokinetics
More informationWHAT IS A PATIENT NAVIGATOR?
PATIENT NAVIGATOR WHAT IS A PATIENT NAVIGATOR? Patient navigation in cancer care refers to individualized assistance offered to patients, families, and caregivers to help overcome health care system barriers
More informationPPP 1. Continuation, modification, and discontinuation of a medication
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
More informationAcross The Chasm: The Transition From Volume To Value
Across The Chasm: The Transition From Volume To Value Joseph Bisordi, MD, Executive Vice President & CMO Ochsner Health System Our Mission is to Serve, Heal, Lead, Educate, and Innovate $1.6 Revenue ($B)
More informationLEADERSHIP PROFILE. Executive Director Gateway Center Atlanta, GA THE OPPORTUNITY
LEADERSHIP PROFILE Executive Director Gateway Center Atlanta, GA The core mission of the Gateway Center is to provide a supportive and compassionate setting where individuals can receive the tools, programs,
More informationPALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE. Chief Pharmacist. Chief Pharmacist
REFERENCE NUMBER: PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE AREA: NAME OF RESPONSIBLE COMMITTEE / INDIVIDUAL NAME OF ORIGINATOR / AUTHOR Trust-wide Chief Pharmacist Chief Pharmacist DATE
More informationCollective Impact Report
National Diabetes Prevention Program State Engagement Model Collective Impact Report EXECUTIVE BRIEF October 2018 State Engagement Model Catalyzes Action and Collective Impact Development of the NACDD/CDC
More informationOrchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department
Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department Dr. Eugene Tso Division of Infectious Diseases Department of Medicine & Geriatrics United Christian Hospital 11 May 2010
More informationMaking Diabetes Prevention a Reality: The National Diabetes Prevention Program
Making Diabetes Prevention a Reality: The National Diabetes Prevention Program Ann Albright, PhD, RD Director, Division of Diabetes Translation Centers for Disease Control and Prevention National Center
More informationMortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project
Libby, MT Sepsis Quality Improvement Project Barb Dumont RN, Director of Quality and Risk Management Mike Julius RN, ED Manager Cathy Wolfe RN, Chief Nursing Officer. Mortality Rate was unsightly!!! percent
More informationFighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program
Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program Joxel Garcia, MD, MBA Executive Director, Cancer Prevention and Control Platform Member, Moon Shots Program Leadership Team The
More informationMALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy
MALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy September 8, 2017 Amy Carr, PharmD PGY-2 Infectious Diseases Pharmacy Resident Seton Healthcare Family amy.carr@ascension.org
More informationThe Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England
The Infection Control Doctor and Clostridium difficile infection Dr David R Jenkins University Hospitals of Leicester NHS Trust, England 250 200 150 100 50 0 Monthly cases of Clostridium difficile (UHL
More informationImplementation of a Successful Seasonal Influenza Vaccine Strategy in a Large Healthcare System
Implementation of a Successful Seasonal Influenza Vaccine Strategy in a Large Healthcare System Edward J. Septimus, MD, FACP, FIDSA, FSHEA Medical Director Infection Prevention and Epidemiology Hospital
More informationTools for Creating a Workplace Culture of Health. Cheryl Bettigole, MD, MPH Philadelphia Department of Public Health September, 2016
Tools for Creating a Workplace Culture of Health Cheryl Bettigole, MD, MPH Philadelphia Department of Public Health September, 2016 CREATING A WORKPLACE CULTURE OF HEALTH Benefits of Choosing the Stairs
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationSession 15 Improved Outcomes and a Proven ROI Model for Quality Improvement: Transforming Diabetes Care
Session 15 Improved Outcomes and a Proven ROI Model for Quality Improvement: Transforming Diabetes Care Charles G Macias MD, MPH Chief Clinical Systems Integration Officer Director of Evidence-Based Outcomes
More informationAnnual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2017
i Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2017 Jessica R. Spencer and Uzo Chukwuma Approved for public release. Distribution is unlimited. The
More informationMercy Defiance Hospital Community Health Needs Assessment Implementation Plan. Introduction
Mercy Defiance Hospital 2014-2016 Community Health Needs Assessment Implementation Plan IDENTIFYING INFORMATION Hospital Name: Mercy Defiance Hospital (MDH) Primary Address: 1404 E. Second Street, Defiance,
More informationStrategic Plan Executive Summary Society for Research on Nicotine and Tobacco
Strategic Plan 2013 2017 Executive Summary Society for Research on Nicotine and Tobacco Prepared By: Corona Insights Corona Insights, 2012 CoronaInsights.com CONTENTS Introduction... 1 Background... 1
More informationWhat CEOs Don t Know about Health System Pharmacy
Pharmacy Executive Forum What CEOs Don t Know about Health System Pharmacy research technology consulting 2 Today s Presenters Rob Lazerow Managing Director The Advisory Board Company lazerowr@advisory.com
More informationExecutive Director s. Update
Executive Director s Update February 2013 Mission, Vision and Values Toastmasters International Mission Vision Values Toastmasters International s core values are integrity, dedication to excellence,
More informationVeterans Health Administration Pharmacy Benefits Management Academic Detailing Services
Veterans Health Administration Pharmacy Benefits Management Academic Detailing Services Melissa Christopher, Pharm.D. National Director, Academic Detailing Services VACO PBM San Diego, California USA Academic
More informationTelepharmacists Reduce Hospital Readmissions
Telepharmacists Reduce Hospital Readmissions Casondra Kleven, PharmD PGY1 Pharmacy Resident University of Cincinnati/ Medication Managers, LLC Brad Hein, BS, PharmD, BCPS Associate Dean for Professional
More informationAnnual Surveillance Summary: Klebsiella species Infections in the Military Health System (MHS), 2017
i Annual Surveillance Summary: Klebsiella species Infections in the Military Health System (MHS), 2017 Tej Mishra and Uzo Chukwuma Approved for public release. Distribution is unlimited. The views expressed
More informationA Decade of Data: Findings and Insights from the National Palliative Care Registry
A Decade of Data: Findings and Insights from the National Palliative Care Registry Maggie Rogers, MPH Senior Research Manager, CAPC Rachael Heitner, MA, CHPCA Research Associate, CAPC July 19, 2018 at
More informationImplementing Standing Orders Protocols Making a Difference in Immunization Rates
Implementing Standing Orders Protocols Making a Difference in Immunization Rates Litjen (L.J.) Tan, MS, PhD Chief Strategy Officer Immunization Action Coalition Co-Chair National Adult and Influenza Immunization
More informationInPHARMation. Pharmacy and Therapeutics Committee Update September 27 th, 2017 Meeting
InPHARMation Pharmacy and Therapeutics Committee Update September 27 th, 2017 Meeting The Pharmacy and Therapeutics Committee at Hendrick Medical Center is a Medical Staff Committee that meets the fourth
More informationMinistry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW
Chapter 1 Section 1.08 Ministry of Health and Long-Term Care Palliative Care Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of Actions Recommended Actions
More informationThe Opioid Crisis Made in America Fade in America?
The Opioid Crisis Made in America Fade in America? The President s Commission On Combating Drug Addiction and the Opioid Crisis Bertha K Madras, PhD Professor of Psychobiology Department of Psychiatry
More informationEthics, Ebola and Epidemiological Issues
Ethics, Ebola and Epidemiological Issues Panel Discussion September 28, 2015 Sponsored by Ethics Committee American College of Epidemiology 2015 Annual Meeting Courtyard by Marriott Hotel Decatur, Georgia
More informationRe: Trust for America s Health Comments on Biennial Implementation Plan for the National Health Security Strategy
Dr. Nicole Lurie, MD, MSPH Assistant Secretary for Preparedness & Response Department of Health and Human Services Washington, DC 20201 Re: Trust for America s Health Comments on Biennial Implementation
More informationTestimony of Robert Egge, Vice President of Public Policy Alzheimer s Association. December 8, 2010
U.S. Senate Special Committee on Aging Until There s A Cure: How to Help Alzheimer s Patients and Families NOW Testimony of Robert Egge, Vice President of Public Policy Alzheimer s Association December
More informationNational Diabetes Prevention Program Centers for Medicare & Medicaid Service Expansion. Tribal Leaders Diabetes Committee September 22, 2016
National Diabetes Prevention Program Centers for Medicare & Medicaid Service Expansion Tribal Leaders Diabetes Committee September 22, 2016 National Diabetes Prevention Program (DPP) Lifestyle change program
More information2017 ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives
2017 ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives Shock Syndromes and Sepsis, Pulmonary Disorders, Hepatic Failure/GI/Endocrine Emergencies, Supportive and
More informationMedicaid s Role in Combating the Opioid Crisis
1 Medicaid s Role in Combating the Opioid Crisis September 23, 2016 Deborah Bachrach Partner Manatt Health Assessing Innovations in Medicaid 1 Medicaid Started as Adjunct to Welfare Programs 2 Eligibility
More informationAmerican College of Healthcare Executives 2018 Chapter Development Report Division of Regional Services March 2018
American College of Healthcare Executives 2018 Chapter Development Report Division of Regional Services March 2018 Since the establishment of chapters in 2004 the Chapter Development Report has tracked
More informationNational Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats
National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats Jean B. Patel, PhD, D(ABMM) Science Lead, Antibiotic Resistance and Coordination Unit Centers for
More informationSuraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable
United States House of Representatives Committee on Appropriations Subcommittee on State and Foreign Operations and Related Programs Fiscal Year 2020 Written Testimony Suraj Madoori, Treatment Action Group,
More informationIntegrating HIPAA Into Your Compliance Program
Integrating HIPAA Into Your Compliance Program Fifth Annual National Congress on Health Care Compliance February 7, 2002 Glenna S. Jackson Vice President Compliance, MedStar Health Diane H. Meyer Chief
More informationPIN BENCHMARKING DATA DEFINITIONS DICTIONARY
CORE MEASURES PIN BENCHMARKING DATA DEFINITIONS DICTIONARY 1 Total number of CAH acute care patient admissions. Report all CAH acute care only patient admissions for the quarter. Exclude CAH swing bed,
More information6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES
First Do No Harm Implementing an Opioid Stewardship Program in a HealthCare System Phil Chang, MD Kristy Deep, MD Doug Oyler, PharmD June 12, 2017 OBJECTIVES Explain the role of opioid stewardship as a
More informationChief Development Officer National Brain Tumor Society
Send Nominations or Cover Letter and Resume to: Lisa Vuona Vice President 617-262-1102 lvuona@lllsearches.com Chief Development Officer National Brain Tumor Society Newton, MA http://braintumor.org/ The
More informationNew York State Immunization Information System (NYSIIS) New York State Department of Health. Digital Government: Government to Business (G to B)
New York State Immunization Information System (NYSIIS) New York State Department of Health Digital Government: Government to Business (G to B) 1 Executive Summary The New York State Immunization Information
More informationWORKING UPSTREAM TO COMBAT THE OPIOID CRISIS
WORKING UPSTREAM TO COMBAT THE OPIOID CRISIS WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association PRESENTER Sarah Derr, PharmD Medication Management Lead Iowa Healthcare
More informationTandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile
Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationphysical mental social
physical mental social Dear Friends of Meridian, Just like the rooms of a house serve important, distinct purposes to make one multipurpose place of living, Meridian s facets of treatment combine for an
More informationNH State HAI Program Overview
New Hampshire Healthcare-Associated Infections (HAI) Annual NHSN Workshop: February 22, 2017 NH State HAI Program Overview Katrina Hansen, MPH, Chief, Infectious Disease Surveillance Healthcare-Associated
More informationAccelero Identifies Opportunities to Provide Greater Value in Hip Fracture Care
Accelero Identifies Opportunities to Provide Greater Value in Hip Fracture Care Every year more than a quarter of a million people over the age of 65 are admitted to a hospital with a hip fracture. Mortality
More informationCollaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home
Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home Background Safety net facility serving the community for more than 140 years Employ over 3500 health
More informationFind Your Perfect 10 Challenge
Find Your Perfect 0 Challenge To meet our community goal,* each hospital has to avoid 0 readmissions per month. That s doable if the community works together! Identify 0 patients who are most at risk for
More informationThe CLSI Approach to Setting Breakpoints
The CLSI Approach to Setting Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic
More informationTogether 2 Goal Innovator Track: Cardiovascular Disease Cohort. Call for Participation
Together 2 Goal Innovator Track: Cardiovascular Disease Cohort Call for Participation Cardiovascular Disease (CVD) and Diabetes Approximately 28 million Americans are living with Type 2 diabetes. Due to
More informationMaking the Most of Your Cancer Registry
www.champsods.com Making the Most of Your Cancer Registry Presenter: Toni Hare, Vice President CHAMPS Oncology Data Services Picture of girl here December 11, 2009 Learning Objectives Upon completion of
More information